bpc 157 human clinical trial tendon injury randomized Stable Gastric Pentadecapeptide and Striated, Smooth, and Heart Muscle BPC-157 for Injury Recovery and
Description
The effectiveness of combining these therapies appears to depend on several factors
BPC-157 is a synthetic peptide originally derived from a protein found in gastric juice and is known for its role in tissue regeneration, injury recovery, and gut health support
[10] The compound promotes angiogenesis and as a result has some concerns over cancer promotion
Eli Lilly's FDA submission is anticipated in late 2026 / early 2027 contingent on Phase 3 TRIUMPH program readouts
Food and Drug Administration (FDA)
